Online, Gut-directed Hypnotherapy for Patients With Irritable Bowel Syndrome (IBS)

Last updated: May 6, 2024
Sponsor: Sahlgrenska University Hospital, Sweden
Overall Status: Active - Recruiting

Phase

N/A

Condition

Colic

Gastrointestinal Diseases And Disorders

Lactose Intolerance

Treatment

Gut-directed hypnotherapy

Clinical Study ID

NCT06297785
2022-03997-01
  • Ages 18-75
  • All Genders

Study Summary

Adult IBS patients with symptoms refractory to standard medical treatment will receive online nurse-administered, gut-directed hypnotherapy in groups. The primary outcome measure was change in gastro-intestinal symptom severity.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • IBS diagnosis

Exclusion

Exclusion Criteria:

  • Organic GI disease

Study Design

Total Participants: 50
Treatment Group(s): 1
Primary Treatment: Gut-directed hypnotherapy
Phase:
Study Start date:
October 17, 2022
Estimated Completion Date:
April 30, 2027

Study Description

IBS patients with symptoms refractory to standard treatment and who were referred to a specialist unit for hypnotherapy, will be included in the study consecutively. The patients will receive gut-directed hypnotherapy given by a nurse trained in Cognitive Behavioral Therapy (CBT) and hypnotherapy. Effects of treatment will be measured by validated questionnaires at baseline and at various time points during the treatment period, as well as after the completion of the treatment at follow-up 6 months, 1 and 2 years after treatment.

Connect with a study center

  • Mag-Tarmlab, Sahlgrenska University Hospital

    Gothenburg, 41345
    Sweden

    Active - Recruiting

  • Sahlgrenska University Hospital

    Gothenburg, 41345
    Sweden

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.